Antiplatelet therapy (APT) is the foundation of treatment and prevention of atherothrombotic
events in patients with atherosclerotic cardiovascular disease. Selecting the optimal APT …

Antiplatelet therapy (APT) has become an important tool in the treatment and prevention of
atherosclerotic events, particularly those associated with coronary artery disease. A large …

Introduction Antiplatelet therapy is the cornerstone for prevention and management of
ischemic complications among patients with coronary artery disease. Over the past decades …

Antiplatelet therapy, mainly consisting of aspirin and P2Y12 receptor antagonists, is the
cornerstone of the pharmacological treatment and prevention of atherothrombotic diseases …

Antiplatelet therapy for patients with coronary artery disease has evolved dramatically over
the last decade. P2Y12 inhibitors offering more potent and consistent platelet inhibition than …

The late interruption of aspirin monotherapy in patients treated with drug-eluting stents has
been incriminated in abrupt late stent thrombosis (1). The fear of late and very late stent …

Antiplatelet therapy in percutaneous coronary intervention:... : Current Opinion in Cardiology
Antiplatelet therapy in percutaneous coronary intervention: latest evidence from randomized …

Abstract The initial 2010 Canadian Cardiovascular Society (CCS) Guidelines for the Use of
Antiplatelet Therapy in the Outpatient Setting were published in May 2011. As part of a …

Recent European Society of Cardiology (ESC) Guidelines have extensively investigated
antithrombotic and antiplatelet therapy during percutaneous coronary interventions (PCI) 1 …

Antiplatelet agents are a cornerstone of therapy for patients with atherosclerotic vascular
disease. There is presently a lack of comprehensive guidelines focusing on the use of …